Observational Study to Investigate Resistant Hypertension Prevalence in Korean General Hospitals (Teveten_RH)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01753206|
Recruitment Status : Completed
First Posted : December 20, 2012
Last Update Posted : January 15, 2015
Study Objectives The study is to identify prevalence, demography and clinical characteristics of patients with resistant hypertension among hypertensive patients who have been treated in general hospitals in Korea from Jan 2012 to Jun 2012.
- Diagnosis of resistant hypertension: In case of clinic blood pressure exceeding the boundary of systolic blood pressure at 140mmHg and diastolic blood pressure at 90mmHg (hereinafter refer to as 140/90mmHg) (130/80mmHg for patients with diabetes mellitus or chronic renal disease) despite triple antihypertensive therapy at optimal dose may be diagnosed as resistant hypertension. Antihypertensive medications used include diuretics. Resistant hypertension may also be diagnosed when clinic blood pressure has reached the target value but quadruple or more of antihypertensives are used.
- Diagnosis of controlled hypertension: Patients whose clinic blood pressure equals to 140/90mmHg (130/80mmHg for patients with diabetes mellitus or chronic renal disease) or less with the administration of antihypertensives at optimal dose may be diagnosed as controlled hypertension.
|Condition or disease|
Prevalence in patients with resistant hypertension among hypertensive patients who have been treated in Korean general hospitals
Analysis of correlation in patients with resistant hypertension and patients with controlled hypertension who received triple antihypertensive therapy in terms of demography, clinical characteristics and other factors
- Demographic data (age, sex, and body mass index)
- Vital signs
- Lifestyles (history of drinking, smoking, and exercise)
- Family history (hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, renal/adrenal disease, cerebrovascular disease, and respiratory disease)
- Concurrent diseases (diabetes mellitus, dyslipidemia, cardiovascular disease, renal/adrenal disease, cerebrovascular disease, respiratory disease, and others)
- History of antihypertensive therapy (past and present)
- Medication compliance of antihypertensives
- Concomitant medications
|Study Type :||Observational|
|Actual Enrollment :||1579 participants|
|Official Title:||Observational Study to Investigate Resistant Hypertension Prevalence Among the Hypertensive Patients Who Have Been Treated in Korean General Hospitals|
|Study Start Date :||February 2013|
|Actual Primary Completion Date :||July 2014|
|Actual Study Completion Date :||July 2014|
- Prevalence of resistant hypertension [ Time Frame: up to 6 months ]Prevalence of resistant hypertension will be estimated, and its 95% confidence interval will be calculated. In addition, proportion of controlled hypertensive patients and its 95% confidence interval will be calculated.
- Analysis of correlation in patients with resistant hypertension and patients with controlled hypertension who received triple antihypertensive therapy in terms of demography, clinical characteristics and other factors [ Time Frame: up to 6 months ]Clinical characteristics in subjects diagnosed of resistant hypertension and those diagnosed of controlled hypertension will be described in summary.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01753206
|Korea, Republic of|
|Seoul National University Bundang Hospital|
|Seongnam-si, Bundang-gu, Korea, Republic of, 463-717|
|Principal Investigator:||Dong-Ju Choi, MD||Seoul National University Bundang Hospital|